Feasibility Trial for HPV Vaccine Hesitancy Campaign
This study is testing a program called "Appalachian Voices for Health" to see if it can help reduce concerns about the Human Papillomavirus (HPV) vaccine. The program involves two main parts: first, health sciences students will create public service announcements (PSAs) about HPV vaccination. Then, these PSAs will be used in a 12-week social marketing campaign shared with community members who use a regional health non-profit's rideshare buses or social media. The main goal is to see if this campaign can change people's feelings about the HPV vaccine, measured by a special survey called the Vaccination Hesitancy Scale (VHS-HPV). We don't know the current recruitment status, but the study plans to enroll 220 people. You might be able to join if you are 18 or older and are either a health sciences student at a regional community college (for the PSA development phase) or if you use the rideshare buses or social media of the health non-profit (for the social marketing campaign phase).
- Study design
- This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 220 participants.
- What's involved
- If you are a student, you will develop PSAs and watch training webinars. If you are a community member, you will be exposed to a 12-week social marketing campaign and complete surveys over a 14-week period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Community members will be assessed pre- and post-intervention over a 14-week period. Students will be assessed pre- and post-intervention over a 6-week period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Vaccination hesitancy scale modified for the HPV vaccine (VHS-HPV)Change in community members' self-reported VHS-HPV score pre-post intervention (14 week period / Phase 2)
validated instrument; 9 items on a response scale of 1-5 (strongly disagree to strongly agree) with higher scores indicating greater hesitancy
- Vaccination hesitancy scale modified for the HPV vaccine (VHS-HPV)Change in Health Sciences students' self-reported VHS-HPV score pre-post intervention (6 week period / Phase 1)
validated instrument; 9 items on a response scale of 1-5 (strongly disagree to strongly agree) with higher scores indicating greater hesitancy